{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:35:11Z","timestamp":1787315711582,"version":"build-2736575974"},"reference-count":26,"publisher":"The Editorial Committee of Annals of Vascular Diseases","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Vascular Diseases","Ann Vasc Dis","AVD"],"published-print":{"date-parts":[[2018]]},"DOI":"10.3400\/avd.ra.18-00002","type":"journal-article","created":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T17:21:13Z","timestamp":1519924873000},"page":"52-56","source":"Crossref","is-referenced-by-count":23,"title":["What Is Vascular Beh\u00e7et\u2019s Disease?"],"prefix":"10.3400","volume":"11","author":[{"given":"Hiroyuki","family":"Ishibashi","sequence":"first","affiliation":[{"name":"Vascular Surgery, Aichi Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1983","reference":[{"key":"1","unstructured":"1) http:\/\/www.nanbyou.or.jp\/entry\/330. Accessed 8 December 2016."},{"key":"2","unstructured":"2) https:\/\/www.uptodate.com\/contents\/clinical-manifestations-anddiagnosis-of-behcets-syndrome? Accessed 8 December 2016."},{"key":"3","unstructured":"3) Beh\u00e7et\u2019s disease. In: Cronenwett JL, Johnston KW eds. Rutherford\u2019s Vascular Surgery, 8th edition. Philadelphia: Elsevier, 2014: 1160-2."},{"key":"4","unstructured":"4) Ishigatsubo Y, Takeno M. Overview. In: Ishigatsubo Y ed. Beh\u00e7et\u2019s Disease. Tokyo: Springer, 2015: 1-20."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Yurdakul S, Hamuryudan V, Yazici H. Beh\u00e7et\u2019s syndrome. Curr Opin Rheumatol 2004; 16<\/b>: 38-42.","DOI":"10.1097\/00002281-200401000-00008"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Calamia KT, Wilson FC, Icen M, et al. Epidemiology and clinical characteristics of Beh\u00e7et\u2019s disease in the US: a population-based study. Arthritis Rheum 2009; 61<\/b>: 600-4.","DOI":"10.1002\/art.24423"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised international chapel hill consensus conference nomenclature of vasculitides. Arthritis Rheum 2013; 65<\/b>: 1-11.","DOI":"10.1007\/s10157-013-0869-6"},{"key":"8","unstructured":"8) Takeno M, Ideguchi H, Suda A, et al. Vascular involvement of Beh\u00e7et\u2019s disease. In: Ishigatsubo Y ed. Beh\u00e7et\u2019s Disease. Tokyo: Springer Japan, 2015: 79-100."},{"key":"9","unstructured":"9) Akpolat T, Koc Y, Yeniay I, et al. Familial Beh\u00e7et\u2019s disease. Eur J Med 1992; 1<\/b>: 391-5."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Ideguchi H, Suda A, Takeno M, et al. Beh\u00e7et disease: evolution of clinical manifestations. Medicine 2011; 90<\/b>: 125-32.","DOI":"10.1097\/MD.0b013e318211bf28"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Cheon JH, Kim WH. An update on the diagnosis, treatment, and prognosis of intestinal Beh\u00e7et\u2019s disease. Curr Opin Rheumatol 2015; 27<\/b>: 24-31.","DOI":"10.1097\/BOR.0000000000000125"},{"key":"12","unstructured":"12) International Study Group for Beh\u00e7et\u2019s Disease. Criteria for diagnosis of Beh\u00e7et\u2019s disease. Lancet 1990; 335<\/b>: 1078-80."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Davatchi F, Assaad-Khalil S, Calamia KT, et al. The international criteria for Beh\u00e7et\u2019s disease: a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol 2014; 28<\/b>: 338-47.","DOI":"10.1111\/jdv.12107"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Mason RM, Barnes CG. Beh\u00e7et\u2019s syndrome with arthritis. Ann Rheum Dis 1969; 28<\/b>: 95-103.","DOI":"10.1136\/ard.28.2.95"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Kim HA, Choi KW, Song YW. Arthropathy in Beh\u00e7et\u2019s disease. Scand J Rheumatol 1997; 26<\/b>: 125-9.","DOI":"10.3109\/03009749709115831"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Sarica-Kucukoglu R, Akdag-Kose A, Kayabali M, et al. Vascular involvement in Beh\u00e7et\u2019s disease: a retrospective analysis of 2319 cases. Int J Dermatol 2006; 45<\/b>: 919-21.","DOI":"10.1111\/j.1365-4632.2006.02832.x"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Fei Y, Li X, Lin S, et al. Major vascular involvement in Beh\u00e7et\u2019s disease: a retrospective study of 796 patients. Clin Rheumatol 2013; 32<\/b>: 845-52.","DOI":"10.1007\/s10067-013-2205-7"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Uzun O, Akpolat T, Erkan L. Pulmonary vasculitis in Beh\u00e7et disease: a cumulative analysis. Chest 2005; 127<\/b>: 2243-53.","DOI":"10.1378\/chest.127.6.2243"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Balcioglu O, Ertugay S, Bozkaya H, et al. Endovascular repair and adjunctive immunosuppressive therapy of aortic involvement in Beh\u00e7et\u2019s disease. Eur J Vasc Endovasc Surg 2015; 50<\/b>: 593-8.","DOI":"10.1016\/j.ejvs.2015.07.011"},{"key":"20","unstructured":"20) Nitecki SS, Ofer A, Karram T, et al. Abdominal aortic aneurysm in Beh\u00e7et\u2019s disease: new treatment options for an old and challenging problem. Isr Med Assoc J 2004; 6<\/b>: 152-5."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Kim WH, Choi D, Kim JS, et al. Effectiveness and safety of endovascular aneurysm treatment in patients with vasculo-Beh\u00e7et disease. J Endovasc Ther 2009; 16<\/b>: 631-6.","DOI":"10.1583\/09-2812.1"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Yang SS, Park KM, Park YJ, et al. Peripheral arterial involvement in Beh\u00e7et\u2019s disease: an analysis of the results from a Korean referral center. Rheumatol Int 2013; 33<\/b>: 2101-8.","DOI":"10.1007\/s00296-013-2700-9"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Goksel OS, Torlak Z, Cinar B, et al. Midterm results with endovascular approach to abdominal aortic pathologies in Beh\u00e7et\u2019s disease. Ann Vasc Surg 2012; 26<\/b>: 277.e5-9.","DOI":"10.1016\/j.avsg.2011.06.010"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Ahn JK, Lee YS, Jeon CH, et al. Treatment of venous thrombosis associated with Beh\u00e7et\u2019s disease: immunosuppressive therapy alone versus immunosuppressive therapy plus anticoagulation. Clin Rheumatol 2008; 27<\/b>: 201-5.","DOI":"10.1007\/s10067-007-0685-z"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Desbois AC, Wechsler B, Resche-Rigon M, et al. Immunosuppressants reduce venous thrombosis relapse in Beh\u00e7et\u2019s disease. Arthritis Rheum 2012; 64<\/b>: 2753-60.","DOI":"10.1002\/art.34450"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Hibi T, Hirohata S, Kikuchi H, et al. Infliximab therapy for intestinal, neurological, and vascular involvement in Beh\u00e7et disease: efficacy, safety, and pharmacokinetics in a multicenter, prospective, open-label, single-arm phase 3 study. Medicine (Baltimore) 2016; 95<\/b>: e3863.","DOI":"10.1097\/MD.0000000000003863"}],"container-title":["Annals of Vascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/avd\/11\/1\/11_ra.18-00002\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T23:48:07Z","timestamp":1570837687000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/avd\/11\/1\/11_ra.18-00002\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.3400\/avd.ra.18-00002","relation":{},"ISSN":["1881-641X","1881-6428"],"issn-type":[{"value":"1881-641X","type":"print"},{"value":"1881-6428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}